| Institution: | 1. Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and Royal Marsden Hospital, London, UK;2. Department of Medicine, David Geffen School of Medicine, Los Angeles, USA;3. Department of Medicine, Hospital Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain;4. Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea;5. Department of Medicine, University of Pennsylvania, Philadelphia, USA;6. Klinik und Poliklinik fuer Frauenheilkunde Klinikum Rechts der Isar, Technische Universitaet Muenchen, Munich, Germany;7. Department of Clinical Research, Institut Curie, Paris, France;8. Department of Breast Medical Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, USA;9. State Budget Medical Institution Republican Clinical Oncology Dispensary, Ufa, Russia;10. European Institute of Oncology, Milan, Italy;11. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago;12. Pfizer Inc, La Jolla, USA;13. Pfizer S.r.l, Milan, Italy;14. Pfizer Inc, New York, USA;15. Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada;1. Department of Mechanical Engineering, The University of Akron, Akron, OH, USA;2. Timken Engineered Surface Laboratories, The University of Akron, Akron, OH, USA;3. The Timken Company, North Canton, OH, USA |
